Ben Cole retweeted
A "Tweetorial"
Today the @FDA updated aficamten's label based on the results of MAPLE HCM, which randomized patients to metoprolol vs aficamten. If you want to learn more about BB use in #HCM, and the updated label, follow along.
First - why a label update?
#cardiotwitter
Ben Cole retweeted
Key lesson from ISCHEMIA-EXTEND
Drawing firm conclusions based on unplanned interim analysis of an imprecisely ascertained outcome (CV death) is a slippery slope!
Most relevant outcome is all-cause mortality and PCI did not move this outcome at early or extended follow-up.
ISCHEMIA EXTEND (null mortality)
Median f/u 5.7y (not prespecified)
ACM: 1.0, 0.85-1.18
CV deaths: 0.78, 0.63-0.96
nonCV deaths: 1.44, 1.08-1.91
Median f/u 9y (prespecified)
ACM: 0.97, 0.86-1.09
CV deaths: 0.88, 0.75-1.02
nonCV deaths: 1.18, 0.96-1.45
jamanetwork.com/journals/jam…
Ben Cole retweeted
3D segmentation of the tricuspid valve – Step by step with 3D Auto TV #philips. Static review → Commissure points → Dynamic review → Analysis.
Ben Cole retweeted
#JADEL
Here's my @JournalASEcho recommended read:
doi.org/10.1016/j.echo.2026.…
E-TAP: Novel Echo Risk Stratification Score in Assessment of Tamponade & Decision-Making for Pericardiocentesis
* Provides a guide for fellows looking to do RCT!
@ASE360
Ben Cole retweeted
PROGRESS trial: Transfemoral TAVR achieved a significant reduction in the primary composite endpoint of death or heart failure event at 2-year follow-up in patients with moderate aortic stenosis and at least one at-risk feature, demonstrating superior clinical outcomes over clinical surveillance.
Download slides here: clinicaltrialresults.org/wp-…
Hearts from young donors age rapidly in the bodies of older recipients, and older hearts are rejuvenated inside young people
go.nature.com/4rzzsHf
Ben Cole retweeted
This is an amazing video. We should be learning from our history and each other. Worth a listen!
Ben Cole retweeted
Here is our investigator initiated pII trial of evuzamitide PET/MRI in cardiac amyloidosis. First ever evuzamitide PET/MRI investigation as well.
126 patients
Excellent diagnostic accuracy even when PYP/HDP were negative (see example in paper)
Pan amyloid
Quantitative
Mutli organ assessment (data not shown here)
pdf.sciencedirectassets.com/…
Ben Cole retweeted
“The strict zero falls policy and the fall prevention procedures add intense stress to health care professionals. Studies have shown that nurses experience fear of patients falling, which is associated with guilt and shame. Nurses feel blamed for the patient’s fall even if an injury was prevented. Subsequently, health care professionals often restrict patients’ mobility to prevent falls even though this decreases patients’ physical function and leads to poor health outcomes.6 Hospital staff often fear litigation after a patient fall, which affects their work-related well-being and promotes the desire to leave the profession.”
Institutional Fear of Falls—Causes, Consequences, and Cures jamanetwork.com/journals/jam…
Ben Cole retweeted
In a difficult and dangerous world, a decade on from Brexit, there is a risk that Britain loses the confidence to lead and stand up for its values.
I’m not prepared to let that happen. It is more important than ever that Britain stands for something.
We have called for years for a two-state solution in the Middle East, but we must recognise that those words are meaningless unless we back them up with action.
For too long, we have been hesitant to act, fearful of being accused of being anti-Israel.
Today we are announcing carefully judged, targeted steps that are not aimed at the Israeli people, but at the unacceptable policies of the current Israeli government.
The suffering of the Palestinian people is a scar on the conscience of the world. Innocent Palestinians, including children, continue to be killed in Gaza. And there is still a humanitarian crisis, with far too little aid getting in.
The scale of destruction is hard to comprehend. More than 70,000 people lie dead - at least 20,000 of them children. Families and communities have been torn apart. Millions displaced. And the population of Gaza is now penned into just one third of the territory.
I know that people across the UK feel very deeply about this issue - and so do I.
Before I became Prime Minister, I said our country’s response had been too slow and simply not good enough. That’s why I committed to changing the government’s approach.
I will not stand by as the horrific suffering continues to grow and the prospect of a two-state solution - the best hope for peace and stability in the region - comes under attack.
More settlements have been approved under the four years of this Israeli government than in the previous 20 years. The UN has reported more than 1,500 incidents of settler violence so far this year, aimed at driving out Palestinians. And the situation is growing worse, fast.
The Israeli government has now approved 104 new settlements since it took office in December 2022, and ahead of the October elections in Israel, it is allowing tenders for the construction of the E1 mega settlement to go ahead. This would cut a swathe through the heart of the West Bank - snuffing out the hope of realising a two-state solution. It cannot be allowed to happen.
That’s why we are announcing a new package of tough measures to put pressure on the Israeli government:
First, we will ban the trade in goods with illegal settlements in Palestine.
Second, we have formally changed the view of the British government to say for the first time that the Israeli occupation of Palestinian territory is unlawful - independent of, but in line with, the conclusion of the international court of justice.
And third, we will sanction individuals and companies that support, facilitate or profit from illegal settlements. That includes any businesses or investors that take part in the construction of the E1 settlement.
In addition, we are announcing a new package of desperately needed humanitarian aid to Gaza.
We are taking these steps because it is the right thing to do.
I have condemned the monstrous terrorist attack on Israel on 7 October 2023 in the strongest possible terms - and continue to condemn Hamas. However, it does not justify the Israeli government’s actions in Gaza or the West Bank.
The measures we are taking are about targeting illegal settlements and increasing the pressure on the Israeli government to change course. We are not imposing sanctions on Israel as a whole, which would punish the Israeli people, many of whom disagree with their government’s position.
The Israeli people are not responsible for the actions of their government. And nor is the Jewish community in the UK. Blaming British Jews for the actions of Benjamin Netanyahu’s government is wrong, plain and simple. And it is antisemitism, plain and simple.
I met the representatives of the Jewish community just last week. I know the fear they live with day by day. My government will stop at nothing to ensure they are safe and to stamp out antisemitism in every part of our society.
The measures we are announcing today are about protecting the only solution that could see the Israeli and Palestinian people living side by side in peace and security - something that people up and down the UK desperately want to see.
The government I lead will keep working with our partners around the world to keep that hope alive.
Ben Cole retweeted
This is can-kicking.
Clinicians are clear: the status quo isn't an option and time is not on our side.
The choice is managed transformation or service collapse. The latter risks patients; the former needs leadership, vision and courage.
Populism and avoidance won't cut it.
Ulster Unionist Health Minister Robbie Butler MLA has today set out his approach to the future of hospital services across Northern Ireland, following the public consultation on Hospitals – Creating a Network for Better Outcomes.
With almost 30,000 written responses received, the Minister said the message from the public is clear: reform is needed, but it must be done differently.
The Minister has set out a number of key actions:
🔵 Hospital categorisation proposals will not be progressed at this stage, with a review of the proposed model and terminology to take place.
🔵 A new Independent Reconfiguration Committee will be established to provide independent expert scrutiny of major or controversial proposals for permanent changes to health and social care services.
🔵 The Committee will examine patient safety, service quality, clinical effectiveness, sustainability, evidence and consultation, with its advice published for transparency.
🔵 Existing guidance on the change or withdrawal of services will be reviewed, including requirements around evidence, transparency, early engagement and rural and equality impacts.
🔵 The Department’s Transport Strategy for Health and Social Care will also be reviewed, recognising the impact of travel distances, ambulance capacity and public transport on patients, particularly in rural communities.
The Minister has been clear that services should continue to be delivered locally wherever this can be done safely and sustainably, while recognising that some specialist services may need to be delivered on a regional or networked basis.
Following visits to South West Acute Hospital and Causeway Hospital, Minister Butler has also emphasised the importance of listening directly to clinicians, staff, patients and communities before major decisions are taken.
Minister Butler’s message is clear: reform is necessary, but it must be evidence led, properly scrutinised and focused on delivering the best outcomes for patients.
“We really need to do reform better.”
Ben Cole retweeted
Didn’t notice this before:
In TRIC-1-HF, there’s no difference in HFH until exactly 1 month, at which time the curves separate sharply and HFH accelerates rapidly in the medical therapy arm.
That’s when crossovers were first allowed (1 month). That’s not a coincidence.
Ben Cole retweeted
Among patients with syncope that remained unexplained after evaluation in the emergency department, the use of 14-day ambulatory ECG monitoring did not result in significantly fewer patient-reported syncope episodes at 1 year than standard care. nejm.org/doi/full/10.1056/NE…
Ben Cole retweeted
10 key takeaways — #ACACIA-HCM
🫀 First positive phase 3 trial in symptomatic nonobstructive HCM.
👥 517 patients: aficamten 5–20 mg vs placebo.
✅ Both primary endpoints were met at week 36.
🟢 KCCQ-CSS improved by +3.0 points vs placebo (P=.02).
#ESCCongress #HCM #Aficamten
Ben Cole retweeted
Replying to @DorbalaSharmila
@DorbalaSharmila presented the results of the #REVEAL study - Evuzamitide PET/CT in cardiac amyloidosis
Amazing results of this first ever rigorously conducted multicenter trial of an imaging agent in cardiac amyloidosis
We are so thankful for the commitment of patients and investigators to the conduct of this investigator initiated trial.
Simultaneously published in @JAMA_current
jamanetwork.com/journals/jam…
#cardiotwitter
#ESC2026
#ESCCongress
#ESCCongress2026
#ESCCongressMedIQ
Ben Cole retweeted
Excited to see our work on myocardial fibrosis and reverse remodelling after AVR for chronic aortic regurgitation published in @JAMACardio! lnkd.in/eCcS-BjD
At 7 months post AVR:
🔹 LVEDV ↓44%
🔹 LV mass ↓21%
🔹 Matrix ↓15%
But focal scar did not regress #whyCMR @TheBHF
Ben Cole retweeted
Postural Orthostatic Tachycardia Syndrome jamanetwork.com/journals/jam…
Ben Cole retweeted
The 10 trials I am most looking forward to at the ESC Hot Lines next week (in no particular order):
LIBREXIA-ACS, where milvexian could end up like apixaban in APPRAISE-2, perhaps with less bleeding. Rivaroxaban did not exactly have an easy story after ATLAS ACS 2 either, despite the positive results. Although we know the trial was stopped for futility, the data remain important in the rollercoaster of FXI inhibitor trials.
EPIDAURUS, because I will be the Discussant in Hot Line 3. It compares ticagrelor or prasugrel with clopidogrel in patients with atrial fibrillation and acute coronary syndrome. So I know everything about it, but I am not telling you.
SWITCH-SWEDEHEART, because if this trial is positive for prasugrel, this might finally be the moment when I call back all my patients on ticagrelor and switch them one by one. If not, we can say we have been joking all along and that ISAR-REACT 5 was just an episode.
PREMIUM, because after NEOMINDSET and STOPDAPT-3, a third negative trial for an aspirin-free strategy (meaning P2Y12 inhibitor monotherapy from the outset) would probably put this rather radical idea to rest, making it indefensible.
ISOLEDS, comparing OCT- versus IVUS-guided PCI in distal left main disease. After OPTIMAL and IVUS-CHIP, which we are still recovering from, we really need something that leaves angiography out of the comparison.
TAVI-PCI, because I don’t know about you, but after NOTION-3 and PRO-TAVI, I am still somewhat confused.
POPular-ACE, one of my favourites because it addresses a simple question with a potentially clear answer that we could implement in the cath lab the very next day: do we actually need protamine after TAVI or not?
AIR-STEMI, continuing the elemental saga of the Ferrara group (the same investigators behind FIRE) this time using angio-derived FFR to identify non-culprit lesions in STEMI. There is some confusion here too, given that FLOWER-MI was negative while FRAME-AMI was positive.
A-CLOSE, evaluating chronic clopidogrel monotherapy and continuing the story started by HOST-EXAM and SMART-CHOICE 3 against aspirin, while resembling OPT-BIRISK in its comparison with DAPT.
PRAGUE-26, which deserves a special mention because I really like the idea of tackling a complicated problem with an extremely simple and inexpensive approach. The results could surprise us and tell us that the solution has been sitting right there all along: alteplase directly instilled into the pulmonary arteries—a strategy we practically never use, and perhaps we are wrong not to.










































